Medicare's intensive behavioral therapy for obesity: An exploratory cost-effectiveness analysis

American Journal of Preventive Medicine

Volumn 48, Issue 4, 2015, Pages 419-425

  Hoerger, Thomas J ^a   Crouse, Wesley L ^a   Zhuo, Xiaohui ^b   Gregg, Edward W ^b   Albright, Ann L ^b   Zhang, Ping ^b  

^a RTI INTERNATIONAL   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BEHAVIOR THERAPY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; EXPLORATORY RESEARCH; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; OBESITY; PRIMARY MEDICAL CARE; QUALITY ADJUSTED LIFE YEAR; REIMBURSEMENT; RISK FACTOR; WEIGHT REDUCTION; COST BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; ECONOMICS; PRIMARY HEALTH CARE; PROBABILITY; STATISTICAL MODEL; UNITED STATES;

AGED; BEHAVIOR THERAPY; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MARKOV CHAINS; MEDICARE; MODELS, ECONOMIC; OBESITY; PRIMARY HEALTH CARE; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES;

EID: 84925351949     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2014.11.008     Document Type: Article

References (20)

1. Centers for Medicare & Medicaid Services (CMS) Decision Memo for Intensive Behavioral Therapy for Obesity 2011 Centers for Medicare & Medicaid Services Baltimore, MD www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx&NcaName=Intensive%20Behavioral%20Therapy%20for%20Obesity&bc=ACAAAAAAIAAA&NCAId=253&
2. E.S. Leblanc, E. O'Connor, E.P. Whitlock, C.D. Patnode, and T. Kapka Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force Ann Intern Med 155 7 2011 434 447 10.7326/0003-4819-155-7-201110040-00006
3. W.H. Herman, T.J. Hoerger, and M. Brandle The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance Ann Intern Med 142 5 2005 323 332 10.7326/0003-4819-142-5-200503010-00007
4. T. Lehnert, D. Sonntag, A. Konnopka, S. Riedel-Heller, and H.H. Konig The long-term cost-effectiveness of obesity prevention interventions: systematic literature review Obes Rev 13 6 2012 537 553 10.1111/j.1467-789X.2011.00980.x
5. Medicare Physician Fee Schedule Search Centers for Medicare and Medicaid Services, Web 29 Mar. 2013
6. The CDC Diabetes Cost-effectiveness Group Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes JAMA 287 19 2002 2542 2551 10.1001/jama.287.19.2542
7. T.J. Hoerger, J.E. Segel, P. Zhang, and S.W. Sorensen Validation of the CDC-RTI Diabetes Cost-Effectiveness Model. RTI Press Methods Report 2009 RTI Press Research Triangle Park, NC 10.3768/rtipress.2009.mr.0013.0909
8. CDC; National Center for Health Statistics (NCHS) National Health and Nutrition Examination Survey Data 2005-2008 U.S. DHHS, CDC Hyattsville, MD www.cdc.gov/nchs/nhanes.htm
9. H.S. Kahn, Y.J. Cheng, T.J. Thompson, G. Imperatore, and E.W. Gregg Two risk-scoring systems for predicting incident diabetes mellitus in U.S. Adults age 45 to 64 years Ann Intern Med 150 11 2009 741 751 10.7326/0003-4819-150-11-200906020-00002
10. M.L. Dansinger, A. Tatsioni, J.B. Wong, M. Chung, and E.M. Balk Meta-analysis: the effect of dietary counseling for weight loss Ann Intern Med 147 1 2007 41 50 10.7326/0003-4819-147-1-200707030-00007
11. W.C. Knowler, E. Barrett-Connor, and S.E. Fowler Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 6 2002 393 403 10.1056/NEJMoa012512
12. R.F. Hamman, R.R. Wing, and S.L. Edelstein Effect of weight loss with lifestyle intervention on risk of diabetes Diabetes Care 29 9 2006 2102 2107 10.2337/dc06-0560
13. G. Davey Smith, Y. Bracha, K.H. Svendsen, J.D. Neaton, S.M. Haffner, and L.H. Kuller Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial Ann Intern Med 142 5 2005 313 322 10.7326/0003-4819-142-5-200503010-00006
14. R.T. Ackermann, S.L. Edelstein, and K.M. Narayan Changes in health state utilities with changes in body mass in the Diabetes Prevention Program Obesity (Silver Spring) 17 12 2009 2176 2181 10.1038/oby.2009.114
15. H. Florez, Q. Pan, and R.T. Ackermann Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trial J Gen Intern Med 27 12 2012 1594 1601 10.1007/s11606-012-2122-5
16. Ali M.K., Echouffo-Tcheugui J., Williamson D.F. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program Health Aff (Millwood). 2012;31(1):67-75. Http://dx.doi.org/10.1377/hlthaff.2011.1009.
17. J. Ma, V. Yank, and L. Xiao Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: a randomized trial JAMA Intern Med 173 2 2013 113 121 10.1001/2013.jamainternmed.987
18. M.S. Lawlor, C.S. Blackwell, and S.P. Isom Cost of a group translation of the Diabetes Prevention Program: Healthy Living Partnerships to Prevent Diabetes Am J Prev Med 44 suppl 4 2013 S381 S389 10.1016/j.amepre.2012.12.016
19. U.S. Bureau of Labor Statistics National occupational employment and wage estimates 2012 www.bls.gov/oes/
20. W.H. Herman, M. Brandle, and P. Zhang Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program Diabetes Care 26 1 2003 36 47 10.2337/diacare.26.1.36